Bisheng Zhou
Dr Bisheng Zhou, PhD is an expert in Biochemistry at University of Illinois at Chicago (United States). Bisheng Zhou has authored 32 publications, the most recent in 2026. SLR score: 93 (community average: 125). How the SLR is computed.
LeadR Profile
Biochemistry
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026
Number : 32
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| From Heterogeneity to Plasticity: Endothelial Dynamics in Lung Disease. PMID 42428584 — cells, lung, homeostasis, pathology, endothelial cells, therapeutics, lung diseases | Pulm Circ | 2026 | 2 |
| Editorial: Uncoupling the Thrombo-inflammatory Loop in Sepsis: FGF10 and the Nrf2-Mitophagy Axis. PMID 42234844 — lung, sepsis, mitophagy | Am J Respir Cell Mol Biol | 2026 | 0 |
| Trained immunity in lung injury and repair. PMID 42079637 — cells, lung, fibrosis, lung injury, immune system diseases, immunity, memory | Front Immunol | 2026 | 0 |
| Roles of Macrophages and Endothelial Cells and Their Crosstalk in Acute Lung Injury. PMID 38540245 — macrophages, therapeutics, acute lung injury, respiratory distress syndrome, endothelial cells | Biomedicines | 2024 | 12 |
| C-type lectin 2D (CLEC2D) is upregulated in clear cell renal cell carcinoma (ccRCC) tissues and predicts poor prognosis. PMID 38509909 — cells, neoplasms, carcinoma, renal cell, lectins, c-type, therapeutics, tissues, prognosis, lectins | Heliyon | 2024 | 0 |
LeadR Networks
Main global connection map